Those with documented allergies to GLP-1 receptor agonists should consult their provider before initiating treatment
Protective effect of L-carnitine versus amifostine against cisplatin-induced [PMID: 21140244] Laboratory literature summary: Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats
Slepnev VI, Ochoa GC, Butler MH, Grabs D, De Camilli P (1998)
In March 2024, the Warnings and Precautions section for doctors in the monograph for Ozempic was updated to state that the Use of GLP-1 receptor agonists may be associated with severe gastrointestinal disease and that Events of delayed gastric emptying, dysgeusia and ileus have been reported
Integrated Metabolic Modeling: Supports studies evaluating coordinated endocrine signaling rather than isolated receptor activation
What the trial did reveal about timing-adjacent factors is more useful